![Mahmood Ladha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mahmood Ladha
Corporate Officer/Principal chez
SWEDISH ORPHAN BIOVITRUM AB
Fortune : 2 M $ au 31/05/2026
Profil
Mahmood Ladha is currently Head-Strategic Transformation Operations at Swedish Orphan Biovitrum AB since 2019.
Formerly, Mr. Ladha was Executive Director & Head-US Respiratory at AstraZeneca AB and President at Dova Pharmaceuticals, Inc. Mr. Ladha completed undergraduate and MBA degrees at the University of South Carolina.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 38 927 ( 0,01 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Mahmood Ladha
| Sociétés | Poste | Début |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de Mahmood Ladha
| Sociétés | Poste | Fin |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | President | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Directeur Général | - |
Formation de Mahmood Ladha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
